The Student Living Lab: Intensive Longitudinal ESM Study for DP of ERFs to Stress in AYAs
Launched by BABES-BOLYAI UNIVERSITY · Apr 24, 2025
Trial Information
Current as of July 06, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial, called "The Student Living Lab," is focused on understanding how young people, specifically adolescents and young adults aged 10 to 24, respond to stress and what helps them be emotionally resilient. Researchers will use mobile devices to collect data on participants' feelings and experiences over time. This will help identify factors that contribute to emotional strength and how past experiences, such as childhood abuse, may affect mental health.
To participate, young people must be between 10 and 24 years old and have parental consent if they're under 18. Unfortunately, those with intellectual disabilities or physical limitations that make it hard to use a computer program will not be eligible. Participants can expect to share their thoughts and feelings through a mobile app, which will help researchers learn more about emotional resilience and stress management. This study is important because it aims to improve mental health support for young individuals facing stress in their lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adolescents and young adults between 10 and 24 years old provided with written parental consent where applicable
- Exclusion Criteria:
- • intellectual disability or physical limitations precluded the use of the computer program
About Babes Bolyai University
Babes-Bolyai University, a prestigious institution located in Cluj-Napoca, Romania, is dedicated to advancing research and innovation in various fields, including healthcare. With a strong emphasis on interdisciplinary collaboration, the university engages in cutting-edge clinical trials aimed at improving patient outcomes and enhancing medical knowledge. Leveraging a robust network of experts and state-of-the-art facilities, Babes-Bolyai University is committed to conducting high-quality research that adheres to ethical standards and contributes to the global scientific community. Through its clinical trial initiatives, the university seeks to foster advancements in treatment methodologies and promote evidence-based practices in medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cluj Napoca, Cluj, Romania
Patients applied
Trial Officials
Oana A. David, Ph.D
Principal Investigator
Babes-Bolyai University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported